Last Updated: August 8, 2026

Suppliers and packagers for TIS-U-SOL


✉ Email this page to a colleague

« Back to Dashboard


TIS-U-SOL

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Baxter Hlthcare TIS-U-SOL magnesium sulfate; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium phosphate SOLUTION;IRRIGATION 018508 NDA Baxter Healthcare Corporation 0338-0190-04 12 BOTTLE, PLASTIC in 1 CARTON (0338-0190-04) / 1000 mL in 1 BOTTLE, PLASTIC 1982-02-19
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for TIS-U-SOL

Last updated: June 17, 2026

TIS-U-SOL Drug Suppliers: Who Manufactures and Supplies This Pharmaceutical Product

Executive summary: No reliable, source-verifiable information is available to identify specific manufacturers, contract manufacturers, finished-dose suppliers, or API suppliers for the pharmaceutical drug TIS-U-SOL. Without authoritative linkage to an active ingredient, dosage form, label strength, NDC/GCN, marketing authorization (FDA NDA/BLA/ANDA), or Orange Book/EMA record, supplier attribution would be speculative.

What company supplies TIS-U-SOL in the US?

No source-backed supplier mapping can be provided because TIS-U-SOL cannot be conclusively matched to a uniquely identifiable FDA-listed product or substance record (e.g., active ingredient + dosage form + strength + labeler/NDC).

Is TIS-U-SOL listed in the FDA Orange Book?

A supplier answer requires Orange Book linkages (listed drug, application number, and patent-bearing status). No verifiable Orange Book listing can be cited for “TIS-U-SOL” based on the provided name.

Is TIS-U-SOL marketed under an ANDA or NDA?

Supplier identification depends on the application-level record (NDA/ANDA/BLA) and its listed manufacturers. No verifiable application mapping exists for “TIS-U-SOL” from the provided information.

Which manufacturers produce TIS-U-SOL dosage forms (tablet, solution, injectable)?

Supplier identification requires a confirmed formulation identity (dosage form and strength). The term “TIS-U-SOL” is insufficient to determine whether the product is, for example, a solution for oral use, infusion solution, or another category.

What is the active ingredient in TIS-U-SOL?

A supplier set is API-dependent. The active ingredient is not provided, so upstream API supplier attribution cannot be sourced.

What is the strength and route for TIS-U-SOL?

Strength and route drive the relevant finished-dose manufacturers and distribution channels. Those attributes are not provided.

Who is the API supplier for TIS-U-SOL?

Upstream API suppliers are identified through:

  • FDA drug substance listings (where available),
  • manufacturing site disclosures in regulatory filings,
  • DMFs and site certifications,
  • commercial supply-chain disclosures.

No source-backed API linkage to “TIS-U-SOL” is possible without an active ingredient and regulatory identifier.

What wholesalers or distributors supply TIS-U-SOL to pharmacies or hospitals?

Distribution suppliers depend on:

  • NDC labeler,
  • wholesale acquisition channel,
  • package configurations and reorder units.

Because TIS-U-SOL is not uniquely identified, no distributor list can be generated from verified records.

How does TIS-U-SOL’s supply chain compare with other products in the same class?

A comparison requires:

  • the therapeutic class,
  • active ingredient,
  • dosage form,
  • target market.

No class match can be established from the provided name alone.

What generic or biosimilar risk affects TIS-U-SOL supply availability?

Generic entry risk is assessed via:

  • ANDA approvals,
  • Paragraph IV filings,
  • FDA exclusivities,
  • Orange Book patent status.

No source-backed regulatory record exists for “TIS-U-SOL,” so entry-risk and supply-diversion scenarios cannot be stated.

What patent or regulatory status governs TIS-U-SOL manufacturing rights?

Manufacturing permissions typically align to:

  • application ownership and exclusivities,
  • process and formulation patents,
  • regulatory transfer constraints.

No patent estate or regulatory status can be tied to “TIS-U-SOL” without a confirmed labeled drug record.

What contract manufacturing (CMO) partners make TIS-U-SOL?

CMO identification depends on:

  • labeler manufacturing site statements,
  • inspection histories tied to a site,
  • corporate disclosures in regulatory filings.

No verifiable manufacturing-site linkage can be provided for “TIS-U-SOL.”

Key Takeaways

  • No verified suppliers can be listed for TIS-U-SOL on the basis of the provided product name alone.
  • Supplier identification requires a uniquely matched drug record (active ingredient, dosage form, strength, and regulatory identifier) to support manufacturer, API, and distributor attribution with citations.

FAQs

  1. How do I find the NDC labeler for TIS-U-SOL?
  2. What FDA database shows finished drug manufacturers for a given drug product?
  3. How can I identify the API supplier using DMF or drug substance records?
  4. Where do contract manufacturing sites appear for marketed pharmaceutical products?
  5. What records confirm distributor availability for a specific NDC package?

References

(No sources cited. No source-verifiable supplier attribution is possible from the provided information.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.